Network meta-analyses (26 studies, 3574 adults): in MAC lung disease, amikacin liposome inhalation suspension plus guideline therapy was linked to higher treatment success (OR 5.74) but more adverse events (OR 3.62); in bacteraemia guideline therapy ranked best.
Meta-analysisn = 3,574
Cheng et al. Comparative efficacy and safety of pharmacological regimens for Mycobacterium avium complex pulmonary disease and bacteremia: A systematic review with separate network meta-analyses